BARCLAYS PLC - BOLT BIOTHERAPEUTICS INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of BOLT BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$01390.0%0.00%
Q2 2023$0139
-5.4%
0.00%
Q1 2023$0
-100.0%
147
-91.2%
0.00%
Q4 2022$21,675
+1105.0%
0.00%
Q3 2022$0139
-46.3%
0.00%
Q2 2022$0
-100.0%
259
-97.3%
0.00%
Q1 2022$26,0009,5550.00%
Other shareholders
BOLT BIOTHERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,891,467$5,183,0002.45%
Nan Fung Group Holdings Ltd 1,166,952$3,197,0001.52%
Vivo Capital, LLC 3,871,291$10,607,0000.73%
Samsara BioCapital, LLC 1,049,153$2,875,0000.72%
Novo Holdings A/S 4,503,991$12,341,0000.65%
Sofinnova Investments, Inc. 2,754,437$7,547,0000.57%
Hawkeye Capital Management, LLC 415,039$1,137,0000.45%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,230,250$6,111,0000.19%
Board of Trustees of The Leland Stanford Junior University 719,546$1,972,0000.11%
Echo Street Capital Management LLC 123,804$5,493,0000.04%
View complete list of BOLT BIOTHERAPEUTICS INC shareholders